AGRYLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Agrylin, and what generic alternatives are available?
Agrylin is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in AGRYLIN is anagrelide hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the anagrelide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Agrylin
A generic version of AGRYLIN was approved as anagrelide hydrochloride by IMPAX LABS on April 18th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AGRYLIN?
- What are the global sales for AGRYLIN?
- What is Average Wholesale Price for AGRYLIN?
Summary for AGRYLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 3 |
| Patent Applications: | 5,177 |
| Drug Prices: | Drug price information for AGRYLIN |
| What excipients (inactive ingredients) are in AGRYLIN? | AGRYLIN excipients list |
| DailyMed Link: | AGRYLIN at DailyMed |
Recent Clinical Trials for AGRYLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shire | Phase 3 |
| Mylan Pharmaceuticals | Phase 1 |
Pharmacology for AGRYLIN
| Drug Class | Platelet-reducing Agent |
| Mechanism of Action | Phosphodiesterase 3 Inhibitors |
| Physiological Effect | Decreased Platelet Production |
US Patents and Regulatory Information for AGRYLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-001 | Mar 14, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-002 | Mar 14, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
